Publicaciones en colaboración con investigadores/as de University Medical Center Hamburg-Eppendorf (1)

2013

  1. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): A randomised phase 3 trial

    The Lancet Oncology, Vol. 14, Núm. 1, pp. 29-37